C
IRadimed Corporation
IRMD
$51.44
-$1.40-2.65%
C
Hold
3/7/2025Downgrade
IRadimed Corporation (IRMD) was downgraded to C+ from B- on 3/7/2025 due to a decline in the valuation index, growth index and volatility index. Operating cash flow declined 34.32% from $9.12M to $5.99M.
IRadimed Corporation (IRMD) was downgraded to C+ from B- on 3/7/2025 due to a decline in the valuation index, growth index and volatility index. Operating cash flow declined 34.32% from $9.12M to $5.99M.
B
Buy
9/30/2024Upgraded
IRadimed Corporation (IRMD) was upgraded to B- from C+ on 9/30/2024 due to a noticeable increase in the growth index, total return index and volatility index. Operating cash flow increased 70.95% from $3.88M to $6.64M, earnings per share increased from $0.32 to $0.38, and EBIT increased 18.51% from $4.75M to $5.63M.
IRadimed Corporation (IRMD) was upgraded to B- from C+ on 9/30/2024 due to a noticeable increase in the growth index, total return index and volatility index. Operating cash flow increased 70.95% from $3.88M to $6.64M, earnings per share increased from $0.32 to $0.38, and EBIT increased 18.51% from $4.75M to $5.63M.
C
Hold
7/3/2024Upgraded
IRadimed Corporation (IRMD) was upgraded to C+ from C on 7/3/2024 due to an increase in the total return index and volatility index.
IRadimed Corporation (IRMD) was upgraded to C+ from C on 7/3/2024 due to an increase in the total return index and volatility index.
C
Hold
6/18/2024Downgrade
IRadimed Corporation (IRMD) was downgraded to C from C+ on 6/18/2024 due to a decline in the total return index and valuation index.
IRadimed Corporation (IRMD) was downgraded to C from C+ on 6/18/2024 due to a decline in the total return index and valuation index.
C
Hold
5/20/2024Upgraded
IRadimed Corporation (IRMD) was upgraded to C+ from C on 5/20/2024 due to an increase in the total return index.
IRadimed Corporation (IRMD) was upgraded to C+ from C on 5/20/2024 due to an increase in the total return index.
C
Hold
5/3/2024Downgrade
IRadimed Corporation (IRMD) was downgraded to C from C+ on 5/3/2024 due to a noticeable decline in the growth index, total return index and efficiency index. Earnings per share declined from $0.3597 to $0.32, net income declined 8.88% from $4.54M to $4.14M, and EBIT declined 7.98% from $5.16M to $4.75M.
IRadimed Corporation (IRMD) was downgraded to C from C+ on 5/3/2024 due to a noticeable decline in the growth index, total return index and efficiency index. Earnings per share declined from $0.3597 to $0.32, net income declined 8.88% from $4.54M to $4.14M, and EBIT declined 7.98% from $5.16M to $4.75M.
C
Hold
4/2/2024Downgrade
IRadimed Corporation (IRMD) was downgraded to C+ from B- on 4/2/2024 due to a noticeable decline in the total return index and solvency index.
IRadimed Corporation (IRMD) was downgraded to C+ from B- on 4/2/2024 due to a noticeable decline in the total return index and solvency index.
B
Buy
3/18/2024Upgraded
IRadimed Corporation (IRMD) was upgraded to B- from C+ on 3/18/2024 due to an increase in the total return index, efficiency index and valuation index.
IRadimed Corporation (IRMD) was upgraded to B- from C+ on 3/18/2024 due to an increase in the total return index, efficiency index and valuation index.
C
Hold
10/17/2023Downgrade
IRadimed Corporation (IRMD) was downgraded to C+ from B- on 10/17/2023 due to a noticeable decline in the total return index and volatility index.
IRadimed Corporation (IRMD) was downgraded to C+ from B- on 10/17/2023 due to a noticeable decline in the total return index and volatility index.
B
Buy
10/2/2023Upgraded
IRadimed Corporation (IRMD) was upgraded to B- from C+ on 10/2/2023 due to an increase in the total return index, valuation index and volatility index.
IRadimed Corporation (IRMD) was upgraded to B- from C+ on 10/2/2023 due to an increase in the total return index, valuation index and volatility index.
C
Hold
9/15/2023Downgrade
IRadimed Corporation (IRMD) was downgraded to C+ from B- on 9/15/2023 due to a noticeable decline in the total return index.
IRadimed Corporation (IRMD) was downgraded to C+ from B- on 9/15/2023 due to a noticeable decline in the total return index.
B
Buy
6/7/2023Upgraded
IRadimed Corporation (IRMD) was upgraded to B- from C+ on 6/7/2023 due to a large increase in the total return index and volatility index.
IRadimed Corporation (IRMD) was upgraded to B- from C+ on 6/7/2023 due to a large increase in the total return index and volatility index.
C
Hold
5/8/2023Upgraded
IRadimed Corporation (IRMD) was upgraded to C+ from C on 5/8/2023 due to a significant increase in the growth index, efficiency index and total return index. Operating cash flow increased 52.89% from $3.04M to $4.65M, and total revenue increased 4.11% from $14.86M to $15.48M.
IRadimed Corporation (IRMD) was upgraded to C+ from C on 5/8/2023 due to a significant increase in the growth index, efficiency index and total return index. Operating cash flow increased 52.89% from $3.04M to $4.65M, and total revenue increased 4.11% from $14.86M to $15.48M.
C
Hold
3/3/2023Downgrade
IRadimed Corporation (IRMD) was downgraded to C from C+ on 3/3/2023 due to a substantial decline in the growth index, volatility index and total return index. Operating cash flow declined 22.84% from $3.94M to $3.04M.
IRadimed Corporation (IRMD) was downgraded to C from C+ on 3/3/2023 due to a substantial decline in the growth index, volatility index and total return index. Operating cash flow declined 22.84% from $3.94M to $3.04M.
C
Hold
5/26/2022Downgrade
IRadimed Corporation (IRMD) was downgraded to C+ from B- on 5/26/2022 due to a noticeable decline in the total return index, volatility index and growth index. Operating cash flow declined 57.63% from $3.37M to $1.43M, and earnings per share declined from $0.3097 to $0.1981.
IRadimed Corporation (IRMD) was downgraded to C+ from B- on 5/26/2022 due to a noticeable decline in the total return index, volatility index and growth index. Operating cash flow declined 57.63% from $3.37M to $1.43M, and earnings per share declined from $0.3097 to $0.1981.
B
Buy
4/18/2022Downgrade
IRadimed Corporation (IRMD) was downgraded to B- from B on 4/18/2022 due to a substantial decline in the total return index and growth index. EBIT declined 89.97% from $3.09M to $309.6, and operating cash flow declined 0.36% from $3.38M to $3.37M.
IRadimed Corporation (IRMD) was downgraded to B- from B on 4/18/2022 due to a substantial decline in the total return index and growth index. EBIT declined 89.97% from $3.09M to $309.6, and operating cash flow declined 0.36% from $3.38M to $3.37M.
B
Buy
2/24/2022Upgraded
IRadimed Corporation (IRMD) was upgraded to B from B- on 2/24/2022 due to an increase in the volatility index, valuation index and total return index.
IRadimed Corporation (IRMD) was upgraded to B from B- on 2/24/2022 due to an increase in the volatility index, valuation index and total return index.
B
Buy
2/16/2022Upgraded
IRadimed Corporation (IRMD) was upgraded to B- from C+ on 2/16/2022 due to a significant increase in the total return index and efficiency index.
IRadimed Corporation (IRMD) was upgraded to B- from C+ on 2/16/2022 due to a significant increase in the total return index and efficiency index.
C
Hold
1/31/2022Downgrade
IRadimed Corporation (IRMD) was downgraded to C+ from B- on 1/31/2022 due to a significant decline in the total return index and volatility index.
IRadimed Corporation (IRMD) was downgraded to C+ from B- on 1/31/2022 due to a significant decline in the total return index and volatility index.
B
Buy
1/7/2022Downgrade
IRadimed Corporation (IRMD) was downgraded to B- from B on 1/7/2022 due to a noticeable decline in the total return index and valuation index.
IRadimed Corporation (IRMD) was downgraded to B- from B on 1/7/2022 due to a noticeable decline in the total return index and valuation index.
B
Buy
12/20/2021Upgraded
IRadimed Corporation (IRMD) was upgraded to B from B- on 12/20/2021 due to a large increase in the total return index and volatility index.
IRadimed Corporation (IRMD) was upgraded to B from B- on 12/20/2021 due to a large increase in the total return index and volatility index.
B
Buy
11/8/2021Upgraded
IRadimed Corporation (IRMD) was upgraded to B- from C+ on 11/8/2021 due to a large increase in the growth index, total return index and valuation index. Earnings per share increased from $0.1194 to $0.2, EBIT increased 67.38% from $1.84M to $3.09M, and total revenue increased 11.18% from $9.81M to $10.91M.
IRadimed Corporation (IRMD) was upgraded to B- from C+ on 11/8/2021 due to a large increase in the growth index, total return index and valuation index. Earnings per share increased from $0.1194 to $0.2, EBIT increased 67.38% from $1.84M to $3.09M, and total revenue increased 11.18% from $9.81M to $10.91M.
C
Hold
10/18/2021Upgraded
IRadimed Corporation (IRMD) was upgraded to C+ from C on 10/18/2021 due to an increase in the volatility index and total return index.
IRadimed Corporation (IRMD) was upgraded to C+ from C on 10/18/2021 due to an increase in the volatility index and total return index.
C
Hold
8/24/2021Downgrade
IRadimed Corporation (IRMD) was downgraded to C from C+ on 8/24/2021 due to a noticeable decline in the total return index and volatility index.
IRadimed Corporation (IRMD) was downgraded to C from C+ on 8/24/2021 due to a noticeable decline in the total return index and volatility index.
C
Hold
8/9/2021Upgraded
IRadimed Corporation (IRMD) was upgraded to C+ from C on 8/9/2021 due to a significant increase in the growth index, total return index and efficiency index. Operating cash flow increased 278.61% from $943.1 to $3.57M, earnings per share increased from $0.11 to $0.1194, and total revenue increased 6.36% from $9.22M to $9.81M.
IRadimed Corporation (IRMD) was upgraded to C+ from C on 8/9/2021 due to a significant increase in the growth index, total return index and efficiency index. Operating cash flow increased 278.61% from $943.1 to $3.57M, earnings per share increased from $0.11 to $0.1194, and total revenue increased 6.36% from $9.22M to $9.81M.
C
Hold
5/25/2021Upgraded
IRadimed Corporation (IRMD) was upgraded to C from C- on 5/25/2021 due to an increase in the total return index and volatility index.
IRadimed Corporation (IRMD) was upgraded to C from C- on 5/25/2021 due to an increase in the total return index and volatility index.
C
Hold
5/10/2021Downgrade
IRadimed Corporation (IRMD) was downgraded to C- from C on 5/10/2021 due to a large decline in the growth index, efficiency index and valuation index. Operating cash flow declined 62.22% from $2.5M to $943.1.
IRadimed Corporation (IRMD) was downgraded to C- from C on 5/10/2021 due to a large decline in the growth index, efficiency index and valuation index. Operating cash flow declined 62.22% from $2.5M to $943.1.
C
Hold
3/25/2021Upgraded
IRadimed Corporation (IRMD) was upgraded to C from C- on 3/25/2021 due to an increase in the total return index and volatility index.
IRadimed Corporation (IRMD) was upgraded to C from C- on 3/25/2021 due to an increase in the total return index and volatility index.
C
Hold
3/5/2021Downgrade
IRadimed Corporation (IRMD) was downgraded to C- from C on 3/5/2021 due to a substantial decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.0878 to $0.0498, net income declined 40.68% from $1.07M to $637.4, and EBIT declined 17.05% from $784.8 to $651.
IRadimed Corporation (IRMD) was downgraded to C- from C on 3/5/2021 due to a substantial decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.0878 to $0.0498, net income declined 40.68% from $1.07M to $637.4, and EBIT declined 17.05% from $784.8 to $651.
C
Hold
11/12/2020Upgraded
IRadimed Corporation (IRMD) was upgraded to C from C- on 11/12/2020 due to a significant increase in the growth index, solvency index and volatility index. EBIT increased 707.9% from -$129.1 to $784.8, earnings per share increased from -$0.1749 to $0.0878, and operating cash flow increased 68.76% from $790.6 to $1.33M.
IRadimed Corporation (IRMD) was upgraded to C from C- on 11/12/2020 due to a significant increase in the growth index, solvency index and volatility index. EBIT increased 707.9% from -$129.1 to $784.8, earnings per share increased from -$0.1749 to $0.0878, and operating cash flow increased 68.76% from $790.6 to $1.33M.
C
Hold
9/15/2020Downgrade
IRadimed Corporation (IRMD) was downgraded to C- from C on 9/15/2020 due to a noticeable decline in the total return index and volatility index.
IRadimed Corporation (IRMD) was downgraded to C- from C on 9/15/2020 due to a noticeable decline in the total return index and volatility index.
C
Hold
8/28/2020Upgraded
IRadimed Corporation (IRMD) was upgraded to C from C- on 8/28/2020 due to an increase in the total return index and valuation index.
IRadimed Corporation (IRMD) was upgraded to C from C- on 8/28/2020 due to an increase in the total return index and valuation index.
C
Hold
8/7/2020Downgrade
IRadimed Corporation (IRMD) was downgraded to C- from C+ on 8/7/2020 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.14 to -$0.1749, net income declined 219.39% from $1.77M to -$2.11M, and EBIT declined 117.51% from $737.2 to -$129.1.
IRadimed Corporation (IRMD) was downgraded to C- from C+ on 8/7/2020 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.14 to -$0.1749, net income declined 219.39% from $1.77M to -$2.11M, and EBIT declined 117.51% from $737.2 to -$129.1.
C
Hold
7/17/2020Upgraded
IRadimed Corporation (IRMD) was upgraded to C+ from C on 7/17/2020 due to an increase in the total return index.
IRadimed Corporation (IRMD) was upgraded to C+ from C on 7/17/2020 due to an increase in the total return index.
C
Hold
6/10/2020Downgrade
IRadimed Corporation (IRMD) was downgraded to C from C+ on 6/10/2020 due to a decline in the total return index and valuation index.
IRadimed Corporation (IRMD) was downgraded to C from C+ on 6/10/2020 due to a decline in the total return index and valuation index.
C
Hold
5/8/2020Upgraded
IRadimed Corporation (IRMD) was upgraded to C+ from C on 5/8/2020 due to an increase in the efficiency index, growth index and total return index. Total capital increased 4.24% from $58.48M to $60.96M.
IRadimed Corporation (IRMD) was upgraded to C+ from C on 5/8/2020 due to an increase in the efficiency index, growth index and total return index. Total capital increased 4.24% from $58.48M to $60.96M.
C
Hold
3/23/2020Downgrade
IRadimed Corporation (IRMD) was downgraded to C from C+ on 3/23/2020 due to a decline in the total return index and volatility index.
IRadimed Corporation (IRMD) was downgraded to C from C+ on 3/23/2020 due to a decline in the total return index and volatility index.
C
Hold
3/6/2020Upgraded
IRadimed Corporation (IRMD) was upgraded to C+ from C on 3/6/2020 due to a large increase in the valuation index, growth index and solvency index. Earnings per share increased from $0.2 to $0.2597, operating cash flow increased 25.83% from $3.14M to $3.95M, and total revenue increased 9.31% from $9.96M to $10.89M.
IRadimed Corporation (IRMD) was upgraded to C+ from C on 3/6/2020 due to a large increase in the valuation index, growth index and solvency index. Earnings per share increased from $0.2 to $0.2597, operating cash flow increased 25.83% from $3.14M to $3.95M, and total revenue increased 9.31% from $9.96M to $10.89M.
C
Hold
5/8/2019Downgrade
IRadimed Corporation (IRMD) was downgraded to C from C+ on 5/8/2019 due to a noticeable decline in the total return index.
IRadimed Corporation (IRMD) was downgraded to C from C+ on 5/8/2019 due to a noticeable decline in the total return index.
C
Hold
4/15/2019Upgraded
IRadimed Corporation (IRMD) was upgraded to C+ from C on 4/15/2019 due to a major increase in the valuation index, total return index and growth index. Operating cash flow increased 386.66% from $727.9 to $3.54M, EBIT increased 23.8% from $1.45M to $1.79M, and total revenue increased 9.52% from $7.61M to $8.34M.
IRadimed Corporation (IRMD) was upgraded to C+ from C on 4/15/2019 due to a major increase in the valuation index, total return index and growth index. Operating cash flow increased 386.66% from $727.9 to $3.54M, EBIT increased 23.8% from $1.45M to $1.79M, and total revenue increased 9.52% from $7.61M to $8.34M.
C
Hold
8/14/2018Upgraded
IRadimed Corporation (IRMD) was upgraded to C from C- on 8/14/2018 due to a substantial increase in the growth index, total return index and volatility index. Earnings per share increased from $0.07 to $0.11, EBIT increased 54.1% from $1.09M to $1.68M, and total revenue increased 3.78% from $7.11M to $7.38M.
IRadimed Corporation (IRMD) was upgraded to C from C- on 8/14/2018 due to a substantial increase in the growth index, total return index and volatility index. Earnings per share increased from $0.07 to $0.11, EBIT increased 54.1% from $1.09M to $1.68M, and total revenue increased 3.78% from $7.11M to $7.38M.
C
Hold
11/28/2017Upgraded
IRadimed Corporation (IRMD) was upgraded to C- from D+ on 11/28/2017 due to an increase in the total return index, valuation index and volatility index.
IRadimed Corporation (IRMD) was upgraded to C- from D+ on 11/28/2017 due to an increase in the total return index, valuation index and volatility index.
D
Sell
11/13/2017Downgrade
IRadimed Corporation (IRMD) was downgraded to D+ from C on 11/13/2017 due to a significant decline in the valuation index, growth index and efficiency index. Net income declined 46.12% from $357.1 to $192.4, EBIT declined 40.14% from $327.6 to $196.1, and earnings per share declined from $0.03 to $0.0182.
IRadimed Corporation (IRMD) was downgraded to D+ from C on 11/13/2017 due to a significant decline in the valuation index, growth index and efficiency index. Net income declined 46.12% from $357.1 to $192.4, EBIT declined 40.14% from $327.6 to $196.1, and earnings per share declined from $0.03 to $0.0182.
C
Hold
8/8/2017Upgraded
IRadimed Corporation (IRMD) was upgraded to C from C- on 8/8/2017 due to an increase in the volatility index and total return index.
IRadimed Corporation (IRMD) was upgraded to C from C- on 8/8/2017 due to an increase in the volatility index and total return index.
C
Hold
6/23/2017Upgraded
IRadimed Corporation (IRMD) was upgraded to C- from D+ on 6/23/2017 due to an increase in the volatility index.
IRadimed Corporation (IRMD) was upgraded to C- from D+ on 6/23/2017 due to an increase in the volatility index.
D
Sell
3/24/2017Downgrade
IRadimed Corporation (IRMD) was downgraded to D+ from C- on 3/24/2017 due to a large decline in the growth index, total return index and valuation index. EBIT declined 41.96% from $2.59M to $1.51M, operating cash flow declined 34.99% from $3.42M to $2.22M, and earnings per share declined from $0.13 to $0.0995.
IRadimed Corporation (IRMD) was downgraded to D+ from C- on 3/24/2017 due to a large decline in the growth index, total return index and valuation index. EBIT declined 41.96% from $2.59M to $1.51M, operating cash flow declined 34.99% from $3.42M to $2.22M, and earnings per share declined from $0.13 to $0.0995.
C
Hold
2/2/2017Downgrade
IRadimed Corporation (IRMD) was downgraded to C- from C on 2/2/2017 due to a large decline in the total return index, volatility index and growth index. Earnings per share declined from $0.19 to $0.13, EBIT declined 22.35% from $3.34M to $2.59M, and total revenue declined 22.25% from $9.87M to $7.67M.
IRadimed Corporation (IRMD) was downgraded to C- from C on 2/2/2017 due to a large decline in the total return index, volatility index and growth index. Earnings per share declined from $0.19 to $0.13, EBIT declined 22.35% from $3.34M to $2.59M, and total revenue declined 22.25% from $9.87M to $7.67M.
C
Hold
8/1/2016Upgraded
IRadimed Corporation (IRMD) was upgraded to C from C- on 8/1/2016 due to an increase in the total return index.
IRadimed Corporation (IRMD) was upgraded to C from C- on 8/1/2016 due to an increase in the total return index.
C
Hold
5/2/2016Upgraded
IRadimed Corporation (IRMD) was upgraded to C- from D+ on 5/2/2016 due to a large increase in the valuation index, growth index and solvency index. Earnings per share increased from $0.15 to $0.1873, operating cash flow increased 9.54% from $2.34M to $2.57M, and the quick ratio increased from 10.05 to 10.65.
IRadimed Corporation (IRMD) was upgraded to C- from D+ on 5/2/2016 due to a large increase in the valuation index, growth index and solvency index. Earnings per share increased from $0.15 to $0.1873, operating cash flow increased 9.54% from $2.34M to $2.57M, and the quick ratio increased from 10.05 to 10.65.
D
Sell
2/1/2016Upgraded
IRadimed Corporation (IRMD) was upgraded to D+ from D on 2/1/2016 due to a large increase in the valuation index, volatility index and efficiency index. Total capital increased 12.06% from $25.09M to $28.11M, and net income increased 5.45% from $1.77M to $1.87M.
IRadimed Corporation (IRMD) was upgraded to D+ from D on 2/1/2016 due to a large increase in the valuation index, volatility index and efficiency index. Total capital increased 12.06% from $25.09M to $28.11M, and net income increased 5.45% from $1.77M to $1.87M.
D
Sell
8/3/2015Upgraded
IRadimed Corporation (IRMD) was upgraded to D from D- on 8/3/2015 due to a significant increase in the growth index, efficiency index and volatility index. EBIT increased 929.24% from $225.4 to $2.32M, net income increased 449.3% from $270.8 to $1.49M, and earnings per share increased from $0.0251 to $0.12.
IRadimed Corporation (IRMD) was upgraded to D from D- on 8/3/2015 due to a significant increase in the growth index, efficiency index and volatility index. EBIT increased 929.24% from $225.4 to $2.32M, net income increased 449.3% from $270.8 to $1.49M, and earnings per share increased from $0.0251 to $0.12.
D
Sell
4/1/2015Upgraded
IRadimed Corporation (IRMD) was upgraded to D- from E+ on 4/1/2015 due to a substantial increase in the total return index, volatility index and growth index. Earnings per share increased from $0.02 to $0.0251.
IRadimed Corporation (IRMD) was upgraded to D- from E+ on 4/1/2015 due to a substantial increase in the total return index, volatility index and growth index. Earnings per share increased from $0.02 to $0.0251.
E
Sell
1/2/2015Upgraded
IRadimed Corporation (IRMD) was upgraded to E+ from E on 1/2/2015 due to a large increase in the volatility index, total return index and solvency index. The quick ratio increased from 2.72 to 9.18.
IRadimed Corporation (IRMD) was upgraded to E+ from E on 1/2/2015 due to a large increase in the volatility index, total return index and solvency index. The quick ratio increased from 2.72 to 9.18.
E
Sell
10/8/2014None
IRadimed Corporation (IRMD) was downgraded to E from U on 10/08/2014.
IRadimed Corporation (IRMD) was downgraded to E from U on 10/08/2014.
NASDAQ
03/13/2025 4:00PM Eastern
Quotes delayed
